Rakovina Therapeutics Inc.
RKV:TSX.V
Streetwise Company Fact Sheet2026/5/12 17:19:12
(RKV:TSX.V)
Analyst coverage
| Leede Financial Inc. — Dr. Douglas Loe |
Company News
| View Latest News |
Streetwise Reports Articles
| 05/06/2026 - View Article |
| 04/24/2026 - View Article |
| 02/24/2026 - View Article |
| 02/09/2026 - View Article |
| 01/12/2026 - View Article |
Streetwise - Rakovina Therapeutics Inc. Ownership Overview*
Rakovina Therapeutics Inc. (RKV:TSX.V)
Restructures
| Date | Old Symbol | Old Shares | New Symbol | New Shares |
|---|---|---|---|---|
| 06/24/25 | RKV | 10 | RKV | 1 |
| 04/01/21 | VCO.P | 1 | RKV | 1 |
*Share Structure as of 5/7/2026
Company News
4/30/2026 – Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update
4/22/2026 – Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting
3/23/2026 – Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 - World's Premier Cancer Research Forum
3/5/2026 – Rakovina Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement Agreements
© 2026 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
